Visit us at ASHP Mid Year in Las Vegas, NV, Booth 1525

New & Noteworthy

Submit New & Noteworthy

April 2010

Subcutaneous Fluid Administration

Baxter Healthcare Corporation

Baxter introduces HYLENEX, an FDA-approved human recombinant hyaluronidase for subcutaneous fluid administration in pediatrics patients. Unlike IV administration, HYLENEX is administered under the skin without the need to secure a vein for treatment initiation. HYLENEX temporarily makes the tissue beneath the skin more permeable, allowing fluids to be more readily absorbed into the blood vessels. HYLENEX has been shown to be safe and effective in infants and young children with mild to moderate dehydration.

Click here to view product detail on Findit.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

Just answer the following quick question for your chance to win:

To continue, you must either login or register: